Your browser doesn't support javascript.
loading
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.
Long, Yingyi; Song, Shuyi; Luo, Feiyang; Han, Xiaojian; Hu, Chao; Wang, Yingming; Li, Shenglong; Wang, Wang; Zhang, Huajun; Zhang, Bo; Li, Tingting; Jin, Aishun.
Afiliação
  • Long Y; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Song S; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Luo F; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Han X; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Hu C; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Wang Y; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Li S; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Wang W; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China.
  • Zhang H; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
  • Zhang B; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
  • Li T; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China. Electronic address: tingtingli1191@cqmu.edu.cn.
  • Jin A; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing, 400010, China; Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing, 400010, China. Electronic address: aishunjin@cqmu.edu.cn.
Biochem Biophys Res Commun ; 571: 152-158, 2021 09 24.
Article em En | MEDLINE | ID: mdl-34325131

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article